Maria C. Melander
Ballerup, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Sym024 Interacts with a Unique Epitope on the CD73 Homodimer, Favoring Effective Bivalent Binding to Improve Anti-PD-1 Therapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 03, 2025
Tumor cell MT1-MMP is dispensable for osteosarcoma tumor growth, bone degradation and lung metastasis.
Journal: Scientific reports
Published: June 18, 2020
CD4+ and CD8a+ PET imaging predicts response to novel PD-1 checkpoint inhibitor: studies of Sym021 in syngeneic mouse cancer models.
Journal: Theranostics
Published: June 11, 2019
Sym004-induced EGFR elimination is associated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models.
Journal: Journal of neuro-oncology
Published: January 23, 2018
The collagen receptor uPARAP/Endo180 as a novel target for antibody-drug conjugate mediated treatment of mesenchymal and leukemic cancers.
Journal: Oncotarget
Published: September 24, 2016
The collagen receptor uPARAP/Endo180 in tissue degradation and cancer (Review).
Journal: International journal of oncology
Published: June 08, 2015
Targeting a novel bone degradation pathway in primary bone cancer by inactivation of the collagen receptor uPARAP/Endo180.
Journal: The Journal of pathology
Published: March 05, 2015
Complex determinants in specific members of the mannose receptor family govern collagen endocytosis.
Complex determinants in specific members of the mannose receptor family govern collagen endocytosis.
Journal: The Journal of biological chemistry
Published: February 07, 2014
Targeting a single function of the multifunctional matrix metalloprotease MT1-MMP: impact on lymphangiogenesis.
Journal: The Journal of biological chemistry
Published: February 16, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026